Acceptability refers to meeting the policymakers, end-users, and health system requirements for a new TB vaccine for adults and adolescents. This includes defining values from various populations, engaging communities as partners in decision-making, and having robust communication strategies in place. This follows from the WHO global framework for country introduction of new adolescent and adult TB vaccines (https://www.who.int/publications/m/item/who-global-framework-to-prepare-for-country-introduction-of-new-tb-vaccines-for-adults-and-adolescents)
Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru
Study asseses knowledge and perception of TB among people in Lima, Peru with particular attention to their willingness and preparedness to participate in a future TB vaccine trial. It examined factors that could influence participation, including knowledge of TB, attitudes towards vaccination, and willingness to participate in research.